January 2022 - Molnupiravir, potentially harmful prescribing and antidepressant withdrawal reactions

January 2022 - Molnupiravir, potentially harmful prescribing and antidepressant withdrawal reactions

BMJ talk medicine

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the January 2022 issue of DTB. They discuss the UK Medicines and Healthcare products Regulatory Agency's decisio…

Related tracks

See all